Baird Maintains Outperform on Qiagen, Raises Price Target to $52
Portfolio Pulse from Benzinga Newsdesk
Baird analyst Catherine Schulte maintains an Outperform rating on Qiagen (NYSE:QGEN) and raises the price target from $49 to $52.
August 02, 2024 | 2:50 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Baird analyst Catherine Schulte maintains an Outperform rating on Qiagen and raises the price target from $49 to $52.
The Outperform rating and increased price target from a reputable analyst can boost investor confidence and potentially drive the stock price higher in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100